Dermatology · Elkin, NC
NPI
1518154889
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
690 Parkwood Medical Park
Elkin, NC, 28621
Phone (336) 835-0165
Groups this clinician bills Medicare through
Medicare paid, 2024
$181K
3,938 services
Medicare patients, 2024
1,000
Average age 76
Drug cost, 2024
$4.1M
2,798 prescriptions
Company payments, 2025
$117K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew D Lee was code 17003 (destruction skin lesion), 1,347 times for 379 patients. In total Andrew D Lee billed 3,938 services in 42 codes, and Medicare paid $181K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-03-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,347 | 379 | $4.62 | $6,227 |
| 99213 Office E&M - Established | Office | 794 | 666 | $59.22 | $47K |
| 17000 Destruction Skin Lesion | Office | 710 | 576 | $41.04 | $29K |
| 99214 Office E&M - Established | Office | 262 | 171 | $84.19 | $22K |
| 11102 Skin Biopsy | Office | 250 | 225 | $69.03 | $17K |
| 99203 Office E&M - New | Office | 154 | 154 | $68.66 | $11K |
| 99212 Office E&M - Established | Office | 77 | 69 | $40.80 | $3,141 |
| 99204 Office E&M - New | Office | 52 | 52 | $112.95 | $5,873 |
| 12032 Wound Repair - All Levels | Office | 46 | 42 | $213.07 | $9,801 |
| 11603 Skin Lesion Excision | Office | 38 | 34 | $122.51 | $4,655 |
| 11103 Skin Biopsy | Office | 32 | 24 | $34.43 | $1,102 |
| 17282 Destruction Skin Lesion | Office | 25 | 23 | $147.19 | $3,680 |
| 17263 Destruction Skin Lesion | Office | 19 | 19 | $147.13 | $2,796 |
| 11604 Skin Lesion Excision | Office | 12 | 12 | $151.36 | $1,816 |
By year: 2022 $229K for 4,826 services; 2023 $199K for 4,479 services; 2024 $181K for 3,938 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew D Lee prescribed most often to Medicare patients was Triamcinolone Acetonide, with 346 prescriptions and refills. In total Andrew D Lee wrote 2,798 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 346 | 408 | 216 | $4,192 |
| Ketoconazole Generic | 340 | 365 | 135 | $4,653 |
| Minocycline Hcl Generic | 314 | 390 | 85 | $4,104 |
| Gabapentin Generic | 180 | 238 | 34 | $3,519 |
| Dupixent Pen Dupilumab | 168 | 171 | 27 | $672K |
| Clobetasol Propionate Generic | 160 | 172 | 87 | $5,789 |
| Betamethasone Dipropionate Generic | 148 | 158 | 87 | $5,637 |
| Finasteride Generic | 96 | 201 | 27 | $501 |
| Fluorouracil Generic | 91 | 94 | 68 | $6,693 |
| Skyrizi Pen Risankizumab-Rzaa | 72 | 191 | 21 | $1.6M |
| Prednisone Generic | 71 | 71 | 42 | $346 |
| Valacyclovir Valacyclovir Hcl | 69 | 75 | 26 | $1,691 |
| Hydroxychloroquine Sulfate Generic | 58 | 74 | 11 | $1,205 |
| Doxycycline Hyclate Generic | 53 | 53 | 41 | $1,063 |
| Ssd Silver Sulfadiazine | 52 | 52 | 22 | $675 |
Brand drugs: 488 claims; generic drugs: 2,310 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew D Lee $117K ($117K in general payments such as food, travel and fees) from 15 companies. The largest payer was Galderma Laboratories, L.P. with $41K.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 53 | $41K |
| Genzyme Corporation SNY | 19 | $28K |
| Organon LLC OGN | 18 | $19K |
| Regeneron Healthcare Solutions, Inc. REGN | 23 | $16K |
| Amgen Inc. AMGN | 12 | $10K |
| Incyte Corporation INCY | 8 | $1,541 |
| Janssen Biotech, Inc. JNJ | 15 | $322 |
| Abbvie Inc. ABBV | 25 | $273 |
| UCB, Inc. UCB.BR | 9 | $164 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $62.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.